Acasti Pharma Inc (ACST) Insider Trading
- $1,292,212.40
- $14,210.07
- Sept. 25, 2023
- Pierre Fitzgibbon
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 25, 2023 | Director | 676,371 | $1.85 | Buy | $1,251,286.35 | |
Aug. 31, 2023 | Director | 381 | $2.05 | Buy | $781.05 | |
June 13, 2017 | Director | 500 | $1.70 | Buy | $850.00 | |
June 12, 2017 | Director | 3,700 | $1.70 | Buy | $6,290.00 | |
May 30, 2017 | Director | 4,500 | $1.69 | Buy | $7,605.00 | |
May 26, 2017 | Director | 5,000 | $1.68 | Buy | $8,400.00 | |
May 25, 2017 | Director | 10,000 | $1.70 | Buy | $17,000.00 | |
Feb. 28, 2017 | Insider | 9,051 | $1.57 | Sell | $14,210.07 |
Insiders are both buying and selling Acasti Pharma Inc stock.
The insider traders at Acasti Pharma Inc are: Pierre Fitzgibbon, Donald Olds, Jean-Daniel Bélanger, and Vimal Kavuru
The most active insider trader at Acasti Pharma Inc is Pierre Fitzgibbon with 5 trades.
Jean-Daniel Bélanger has sold the most Acasti Pharma Inc stock with a total value of $28,420.14.
Vimal Kavuru has bought the most Acasti Pharma Inc stock with a total value of $2,502,572.70.
The most recent insider trade for Acasti Pharma Inc was on Sept. 25, 2023.
The single biggest insider buy for Acasti Pharma Inc was from Vimal Kavuru with a total value of $1,251,286.35 on Sept. 25, 2023.
The single biggest insider sell for Acasti Pharma Inc was from Jean-Daniel Bélanger with a total value of $14,210.07 on Feb. 28, 2017.